NeuPath Health, Inc. (NPTH) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

MedBright AI Investments, Inc.

NeuPath Health, Inc.

Think Research Corp.

Cliffside Capital Ltd.

Edge Total Intelligence, Inc.

RE Royalties Ltd.

Cypherpunk Holdings, Inc.

Fredonia Mining, Inc.

Hispania Resources, Inc.

Tier One Capital LP

Sustainable Power & Infrastructure Split Corp.

Why is NeuPath Health, Inc. ?

The company has declared positive results in Mar'2026 after 2 consecutive negative quarters

NET PROFIT(Q) At CAD 0.48 MM has Grown at 321.06%
ROCE(HY) Highest at 0.04%
PRE-TAX PROFIT(Q) At CAD 0.68 MM has Grown at 136.63%

With ROE of 2.52%, it has a risky valuation with a 1.22 Price to Book Value

Over the past year, while the stock has generated a return of 126.92%, its profits have risen by 73% ; the PEG ratio of the company is 0.1

Market Beating performance in long term as well as near term

Along with generating 126.92% returns in the last 1 year, the stock has outperformed S&P/TSX 60 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Finance)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is NeuPath Health, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

NeuPath Health, Inc.

135.29%

3.40

57.41%

S&P/TSX 60

29.6%

2.24

12.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

12.21%

EBIT Growth (5y)

31.88%

EBIT to Interest (avg)

-0.27

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

100.00%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

1.93%

ROE (avg)

0.16%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.63

EV to EBIT

15.49

EV to EBITDA

8.09

EV to Capital Employed

1.54

EV to Sales

0.42

PEG Ratio

Dividend Yield

ROCE (Latest)

9.93%

ROE (Latest)

4.30%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Bearish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

NET PROFIT(Q)

At CAD 0.48 MM has Grown at 321.06%

ROCE(HY)

Highest at 0.04%

PRE-TAX PROFIT(Q)

At CAD 0.68 MM has Grown at 136.63%

RAW MATERIAL COST(Y)

Fallen by -0.81% (YoY

DEBTORS TURNOVER RATIO(HY)

Highest at 10.39 times

EPS(Q)

Highest at CAD 0.01

-7What is not working for the Company

NET PROFIT(9M)

At CAD -0.87 MM has Grown at -153.77%

OPERATING CASH FLOW(Y)

Lowest at CAD 2.42 MM

DEBT-EQUITY RATIO (HY)

Highest at 45.67 %

Here's what is working for NeuPath Health, Inc.

Net Profit

At CAD 0.48 MM has Grown at 321.06%

over average net sales of the previous four periods of CAD -0.22 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CAD MM)

Pre-Tax Profit

At CAD 0.68 MM has Grown at 136.63%

over average net sales of the previous four periods of CAD 0.29 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CAD MM)

EPS

Highest at CAD 0.01

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CAD)

Debtors Turnover Ratio

Highest at 10.39 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -0.81% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for NeuPath Health, Inc.

Operating Cash Flow

Lowest at CAD 2.42 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CAD MM)

Debt-Equity Ratio

Highest at 45.67 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio